<SEC-DOCUMENT>0001193125-15-035111-index.html : 20150205
<SEC-HEADER>0001193125-15-035111.hdr.sgml : 20150205
<ACCEPTANCE-DATETIME>20150205134402
ACCESSION NUMBER:		0001193125-15-035111
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20150205
DATE AS OF CHANGE:		20150205
GROUP MEMBERS:		ANSBERT GADICKE
GROUP MEMBERS:		JAMES PAUL SCOPA
GROUP MEMBERS:		LUKE EVNIN
GROUP MEMBERS:		MPM BIOVENTURES IV GP LLC
GROUP MEMBERS:		MPM BIOVENTURES IV LLC
GROUP MEMBERS:		TODD FOLEY
GROUP MEMBERS:		VAUGHN M. KAILIAN

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PROTEON THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001359931
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88372
		FILM NUMBER:		15579349

	BUSINESS ADDRESS:	
		STREET 1:		200 WEST STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		781-890-0102

	MAIL ADDRESS:	
		STREET 1:		200 WEST STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MPM Bio IV NVS Strategic Fund LP
		CENTRAL INDEX KEY:			0001423213
		IRS NUMBER:				980508803
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		THE JOHN HANCOCK TOWER
		STREET 2:		200 CLARENDON STREET 54TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-425-9200

	MAIL ADDRESS:	
		STREET 1:		THE JOHN HANCOCK TOWER
		STREET 2:		200 CLARENDON STREET 54TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>d868235dsc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: d868235dsc13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A
<SEQUENCE>2
<FILENAME>d868235dex99a.htm
<DESCRIPTION>EX-A
<TEXT>
Document 2 - file: d868235dex99a.htm

</DOCUMENT>
</SEC-DOCUMENT>